Literature DB >> 24395481

Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome.

Julian Knight1.   

Abstract

An increasing number of genetic association studies have implicated polymorphisms of cytokine genes as host genetic factors influencing susceptibility to infectious disease, primarily using a candidate gene approach based on knowledge of disease pathogenesis. The application and limitations of association studies are reviewed together with the impact of recent advances in single nucleotide polymorphism mapping on strategic approaches to defining genetic susceptibility loci. It often remains unclear whether associated genetic polymorphisms are themselves functionally relevant or acting only as markers within an extended haplotype, and experimental approaches to investigating the functional impact of polymorphisms in noncoding regulatory DNA sequences are discussed. An overview of genetic associations of cytokine genes with infectious disease is presented, together with discussion of recent studies in a number of infectious diseases including hepatitis, HIV, malaria, and sepsis.

Entities:  

Year:  2007        PMID: 24395481     DOI: 10.1007/s11908-007-1010-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  50 in total

Review 1.  Cytokine gene polymorphism in human disease: on-line databases.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

2.  Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis--endemic population.

Authors:  N Mozzato-Chamay; O S Mahdi; O Jallow; D C Mabey; R L Bailey; D J Conway
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  An interleukin-1 genotype is associated with fatal outcome of meningococcal disease.

Authors:  R C Read; N J Camp; F S di Giovine; R Borrow; E B Kaczmarski; A G Chaudhary; A J Fox; G W Duff
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis.

Authors:  R Bellamy; C Ruwende; T Corrah; K P McAdam; H C Whittle; A V Hill
Journal:  Tuber Lung Dis       Date:  1998

5.  Host genetic factors influence disease progression in chronic hepatitis C.

Authors:  E E Powell; C J Edwards-Smith; J L Hay; A D Clouston; D H Crawford; C Shorthouse; D M Purdie; J R Jonsson
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

Authors:  C J Edwards-Smith; J R Jonsson; D M Purdie; A Bansal; C Shorthouse; E E Powell
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

7.  Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.

Authors:  M C Knuchel; T J Spira; A U Neumann; L Xiao; D L Rudolph; J Phair; S M Wolinsky; R A Koup; O J Cohen; T M Folks; R B Lal
Journal:  AIDS Res Hum Retroviruses       Date:  1998-03-01       Impact factor: 2.205

8.  Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes.

Authors:  M Hurme; M Helminen
Journal:  Scand J Infect Dis       Date:  1998

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 10.  Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases.

Authors:  M Hurme; N Lahdenpohja; S Santtila
Journal:  Ann Med       Date:  1998-10       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.